219 related articles for article (PubMed ID: 17717320)
21. SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.
Mesaki K; Yamane M; Sugimoto S; Fujisawa M; Yoshimura T; Kurosaki T; Otani S; Miyoshi S; Oto T; Matsukawa A; Toyooka S
Surg Today; 2019 May; 49(5):443-450. PubMed ID: 30617600
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of the Tracheal Epithelium Can Increase the Number of Recipient Bone Marrow-Derived Myofibroblasts in Allografts and Exacerbate Obliterative Bronchiolitis After Tracheal Transplantation in Mice.
Wang C; Xia T; Jiang K; Qiao X; Zhang X; Li J; Wang J; Nie J
Transplantation; 2016 Sep; 100(9):1880-8. PubMed ID: 27163540
[TBL] [Abstract][Full Text] [Related]
23. Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.
McKane BW; Fernandez F; Narayanan K; Marshbank S; Margolin SB; Jendrisak M; Mohanakumar T
Transplantation; 2004 Mar; 77(5):664-9. PubMed ID: 15021826
[TBL] [Abstract][Full Text] [Related]
24. Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis.
Babu AN; Murakawa T; Thurman JM; Miller EJ; Henson PM; Zamora MR; Voelkel NF; Nicolls MR
J Clin Invest; 2007 Dec; 117(12):3774-85. PubMed ID: 18060031
[TBL] [Abstract][Full Text] [Related]
25. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
[TBL] [Abstract][Full Text] [Related]
26. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet
Lendermon EA; Dodd-O JM; Coon TA; Wang X; Ensor CR; Cardenes N; Koodray CL; Heusey HL; Bennewitz MF; Sundd P; Bullock GC; Popescu I; Guo L; O'Donnell CP; Rojas M; McDyer JF
Transplant Proc; 2018 Jun; 50(5):1566-1574. PubMed ID: 29880387
[TBL] [Abstract][Full Text] [Related]
28. Carbon monoxide-releasing molecule attenuates allograft airway rejection.
Ohtsuka T; Kaseda K; Shigenobu T; Hato T; Kamiyama I; Goto T; Kohno M; Shimoda M
Transpl Int; 2014 Jul; 27(7):741-7. PubMed ID: 24628975
[TBL] [Abstract][Full Text] [Related]
29. Epithelial kinetics in mouse heterotopic tracheal allografts.
Neuringer IP; Aris RM; Burns KA; Bartolotta TL; Chalermskulrat W; Randell SH
Am J Transplant; 2002 May; 2(5):410-9. PubMed ID: 12123205
[TBL] [Abstract][Full Text] [Related]
30. Successful orthotopic transplantation of short tracheal segments without immunosuppressive therapy.
Hysi I; Kipnis E; Fayoux P; Copin MC; Zawadzki C; Jashari R; Hubert T; Ung A; Ramon P; Jude B; Wurtz A
Eur J Cardiothorac Surg; 2015 Feb; 47(2):e54-61. PubMed ID: 25475944
[TBL] [Abstract][Full Text] [Related]
31. Respiratory epithelial expression of integrin alphaVbeta6 in chronic progressive allograft rejection.
Dosanjh A; Ikonen T; Morris R
J Heart Lung Transplant; 2004 Apr; 23(4):456-60. PubMed ID: 15063405
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen water alleviates obliterative airway disease in mice.
Ozeki N; Yamawaki-Ogata A; Narita Y; Mii S; Ushida K; Ito M; Hirano SI; Kurokawa R; Ohno K; Usui A
Gen Thorac Cardiovasc Surg; 2020 Feb; 68(2):158-163. PubMed ID: 31468277
[TBL] [Abstract][Full Text] [Related]
33. Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation.
Suzuki Y; Juvet S; Liu M; Keshavjee S
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38009732
[TBL] [Abstract][Full Text] [Related]
34. Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts.
Mauer J; Kuckhahn A; Ramsperger-Gleixner M; Ensminger SM; Distler JHW; Weyand M; Heim C
Transpl Immunol; 2022 Aug; 73():101608. PubMed ID: 35490983
[TBL] [Abstract][Full Text] [Related]
35. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
36. Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease.
West EE; Lavoie TL; Orens JB; Chen ES; Ye SQ; Finkelman FD; Garcia JG; McDyer JF
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):108-18. PubMed ID: 16195540
[TBL] [Abstract][Full Text] [Related]
37. Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model.
Ramirez AM; Takagawa S; Sekosan M; Jaffe HA; Varga J; Roman J
Am J Pathol; 2004 Oct; 165(4):1223-32. PubMed ID: 15466388
[TBL] [Abstract][Full Text] [Related]
38. FOXP3
Khan MA; Alanazi F; Ahmed HA; Al-Mohanna FH; Assiri AM; Broering DC
Clin Immunol; 2017 Jan; 174():84-98. PubMed ID: 27939405
[TBL] [Abstract][Full Text] [Related]
39. Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance.
Chalermskulrat W; McKinnon KP; Brickey WJ; Neuringer IP; Park RC; Sterka DG; Long BR; McNeillie P; Noelle RJ; Ting JP; Aris RM
Thorax; 2006 Jan; 61(1):61-7. PubMed ID: 16254057
[TBL] [Abstract][Full Text] [Related]
40. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Krebs R; Tikkanen JM; Ropponen JO; Jeltsch M; Jokinen JJ; Ylä-Herttuala S; Nykänen AI; Lemström KB
Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
